Literature DB >> 20638752

Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control?

B Meyer1, B Cookson.   

Abstract

Increased numbers of healthcare-acquired infections, including those caused by antibiotic-resistant microbes, have created a need for improved infection control use of disinfection regimens. Commensurate with this has been an increasing number of reports on resistance to a wide variety of antimicrobials, including biocides. Cross-resistance between these biocides and other biocidal or antimicrobial agents has been well-documented. Much of the literature lacks clear distinctions between adaptation of organisms to exposure to biocides, which reverses upon removal of the biocide, as opposed to resistance. Depending on the genetic basis of this resistance, it may be high level and not readily reversible. This lack of clear definitions complicates the evaluation of the relevance of these phenomena in practice. In this review we propose definitions of adaptative processes and biocide resistance and survey the literature according to these definitions. We conclude that the current risks to healthcare delivery caused by resistance related to biocides are low, provided that biocides are used under appropriate conditions. The need for further research is addressed.
Copyright © 2010 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638752     DOI: 10.1016/j.jhin.2010.05.020

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  33 in total

Review 1.  Quaternary ammonium biocides: efficacy in application.

Authors:  Charles P Gerba
Journal:  Appl Environ Microbiol       Date:  2014-10-31       Impact factor: 4.792

2.  Efflux as a glutaraldehyde resistance mechanism in Pseudomonas fluorescens and Pseudomonas aeruginosa biofilms.

Authors:  Amit Vikram; Jennifer M Bomberger; Kyle J Bibby
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

3.  Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan.

Authors:  Joe Latimer; Sarah Forbes; Andrew J McBain
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

4.  Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents.

Authors:  Jennifer S McDanel; Courtney R Murphy; Daniel J Diekema; Victor Quan; Diane S Kim; Ellena M Peterson; Kaye D Evans; Grace L Tan; Mary K Hayden; Susan S Huang
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

5.  Assessment of the Potential for Inducing Resistance in Multidrug-Resistant Organisms from Exposure to Minocycline, Rifampin, and Chlorhexidine Used To Treat Intravascular Devices.

Authors:  Joel Rosenblatt; Nylev Vargas-Cruz; Ruth A Reitzel; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

6.  Surface-Dried Viruses Can Resist Glucoprotamin-Based Disinfection.

Authors:  Benjamin Zeitler; Ingrid Rapp
Journal:  Appl Environ Microbiol       Date:  2014-09-12       Impact factor: 4.792

7.  Activity of ozonated water and ozone against Staphylococcus aureus and Pseudomonas aeruginosa biofilms.

Authors:  Dariusz Bialoszewski; Anna Pietruczuk-Padzik; Agnieszka Kalicinska; Ewa Bocian; Magdalena Czajkowska; Bozena Bukowska; Stefan Tyski
Journal:  Med Sci Monit       Date:  2011-11

8.  The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia.

Authors:  Alvaro Hernández; Federico M Ruiz; Antonio Romero; José L Martínez
Journal:  PLoS Pathog       Date:  2011-06-30       Impact factor: 6.823

9.  Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation.

Authors:  Julie V Robotham; Nicholas Graves; Barry D Cookson; Adrian G Barnett; Jennie A Wilson; Jonathan D Edgeworth; Rahul Batra; Brian H Cuthbertson; Ben S Cooper
Journal:  BMJ       Date:  2011-10-05

10.  Multidrug Efflux Pumps in Staphylococcus aureus: an Update.

Authors:  Sofia Santos Costa; Miguel Viveiros; Leonard Amaral; Isabel Couto
Journal:  Open Microbiol J       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.